unbiased screening to identify molecular zip codes

AivoCode is an emerging biotech startup developing platform technologies to improve treatment and management of neurological diseases by developing assets that promote neuroprotection and block neuroinflammation. Its technology uses an unbiased screening approach to identify molecular "zip codes" specific to diseased regions or cell types in the brain. It is developing therapeutic antibodies against an unexplored target present early in Alzheimer's disease blood vessels, and exploring therapeutic candidates in optic neuropathies including glaucoma.

Read more

neuroprotection researchtherapeutic antibody development